Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimony and bismuth compounds in oncology.

Literature DB >> 12050016

Antimony and bismuth compounds in oncology.

Abstract

The main group elements antimony and bismuth are used clinically, primarily for the treatment of Leishmaniasis (antimony) and ulcers (bismuth). Despite their medicinal efficacy, the exploration of the anti-cancer potential of antimony and bismuth compounds is not as well developed as for other metal-containing species. The results of cytotoxicity and anti-tumour screening for antimony(III), antimony(V) and bismuth(III) compounds are summarised in this review. While this is a relatively undeveloped field of research endeavour, promising anti-tumour activity has been reported, in particular for bismuth compounds.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 12050016 DOI： 10.1016/s1040-8428(01)00217-7

Source DB: PubMed Journal: Crit Rev Oncol Hematol ISSN： 1040-8428 Impact factor: 6.312

Keyword Cloud
Cited

14 in total

1. Performance assessment of semiempirical molecular orbital methods in the structural prediction of Sb(III) and Bi(III) complexes.

Authors: Evandro Paulo Soares Martins; Gerd B Rocha
Journal: J Mol Model Date: 2013-10 Impact factor: 1.810

2. Synthesis, characterization, antimicrobial and cytotoxic activity and DNA-binding properties of d-metal complexes with hydrazones of Girard's T and P reagents.

Authors: Nevena Stevanović; Paolo Pio Mazzeo; Alessia Bacchi; Ivana Z Matić; Marija Đorđić Crnogorac; Tatjana Stanojković; Miroslava Vujčić; Irena Novaković; Dušanka Radanović; Maja Šumar-Ristović; Dušan Sladić; Bofžidar Čobeljić; Katarina Anđelković
Journal: J Biol Inorg Chem Date: 2021-09-06 Impact factor: 3.358

3. Bistratal Au@Bi₂S₃ nanobones for excellent NIR-triggered/multimodal imaging-guided synergistic therapy for liver cancer.

Authors: Ruizhuo Ouyang; Penghui Cao; Pengpeng Jia; Hui Wang; Tianyu Zong; Chenyu Dai; Jie Yuan; Yuhao Li; Dong Sun; Ning Guo; Yuqing Miao; Shuang Zhou
Journal: Bioact Mater Date: 2020-09-04

4. Tris(O-cyclo-hexyl dithio-carbonato-κS)anti-mony(III).

Authors: Wenkuan Li; Handong Yin; Liyuan Wen; Daqi Wang
Journal: Acta Crystallogr Sect E Struct Rep Online Date: 2008-12-10

5. The effect of novel rhenium compounds on lymphosarcoma, PC-3 prostate and myeloid leukemia cancer cell lines and an investigation on the DNA binding properties of one of these compounds through electronic spectroscopy.

Authors: Carl Parson; Valerie Smith; Christopher Krauss; Hirendra N Banerjee; Christopher Reilly; Jeanette A Krause; James M Wachira; Dipak Giri; Angela Winstead; Santosh K Mandal
Journal: J Bioprocess Biotech Date: 2013-12-27

Antimony and bismuth compounds in oncology.

1. Performance assessment of semiempirical molecular orbital methods in the structural prediction of Sb(III) and Bi(III) complexes.

2. Synthesis, characterization, antimicrobial and cytotoxic activity and DNA-binding properties of d-metal complexes with hydrazones of Girard's T and P reagents.

3. Bistratal Au@Bi₂S₃ nanobones for excellent NIR-triggered/multimodal imaging-guided synergistic therapy for liver cancer.

4. Tris(O-cyclo-hexyl dithio-carbonato-κS)anti-mony(III).

5. The effect of novel rhenium compounds on lymphosarcoma, PC-3 prostate and myeloid leukemia cancer cell lines and an investigation on the DNA binding properties of one of these compounds through electronic spectroscopy.

6. Rapid synthesis of Bi₂O₃ nano-needles via 'green route' and evaluation of its anti-fungal activity.

7. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119

8. The elements of life and medicines.

9. Antimony(V) and bismuth(V) complexes of lapachol: synthesis, crystal structure and cytotoxic activity.

10. Crystal structure, antibacterial and cytotoxic activities of a new complex of bismuth(III) with sulfapyridine.